| Long-term delivery of protein therapeutics R Vaishya, V Khurana, S Patel, AK Mitra Expert opinion on drug delivery 12 (3), 415-440, 2015 | 204 | 2015 |
| Novel delivery approaches for cancer therapeutics AK Mitra, V Agrahari, A Mandal, K Cholkar, C Natarajan, S Shah, ... Journal of controlled release 219, 248-268, 2015 | 194 | 2015 |
| Controlled ocular drug delivery with nanomicelles RD Vaishya, V Khurana, S Patel, AK Mitra Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2014 | 193 | 2014 |
| Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated … M Minocha, V Khurana, B Qin, D Pal, AK Mitra International journal of pharmaceutics 434 (1-2), 306-314, 2012 | 104 | 2012 |
| Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib M Minocha, V Khurana, B Qin, D Pal, AK Mitra International journal of pharmaceutics 436 (1-2), 127-134, 2012 | 87 | 2012 |
| Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography–tandem mass spectrometry (LC/MS–MS) M Minocha, V Khurana, AK Mitra Journal of chromatography B 901, 85-92, 2012 | 64 | 2012 |
| Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery A Mandal, K Cholkar, V Khurana, A Shah, V Agrahari, R Bisht, D Pal, ... Molecular pharmaceutics 14 (6), 2056-2069, 2017 | 61 | 2017 |
| Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors V Khurana, M Minocha, D Pal, AK Mitra Drug metabolism and drug interactions 29 (3), 179-190, 2014 | 54 | 2014 |
| Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors V Khurana, M Minocha, D Pal, AK Mitra Drug metabolism and drug interactions 29 (4), 249-259, 2014 | 48 | 2014 |
| Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir S Luo, Z Wang, M Patel, V Khurana, X Zhu, D Pal, AK Mitra International journal of pharmaceutics 414 (1-2), 77-85, 2011 | 46 | 2011 |
| Encapsulation of protein‐polysaccharide hip complex in polymeric nanoparticles R Gaudana, V Khurana, A Parenky, AK Mitra Journal of drug delivery 2011 (1), 458128, 2011 | 37 | 2011 |
| Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers DA Oh, N Parikh, V Khurana, C Cognata Smith, S Vetticaden Clinical pharmacology: advances and applications, 9-17, 2017 | 35 | 2017 |
| Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme R Gaudana, M Gokulgandhi, V Khurana, D Kwatra, AK Mitra Pharmaceutical development and technology 18 (3), 752-759, 2013 | 34 | 2013 |
| Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers N Parikh, WG Kramer, V Khurana, C Cognata Smith, S Vetticaden Clinical pharmacology: advances and applications, 155-162, 2016 | 31 | 2016 |
| Transporter effects on cell permeability in drug delivery A Mandal, V Agrahari, V Khurana, D Pal, AK Mitra Expert opinion on drug delivery 14 (3), 385-401, 2017 | 26 | 2017 |
| Novel Pentablock Copolymer Based Nanoparticles Containing Pazopanib: A Potential Therapy for Ocular Neovascularization V Khurana, P Sulabh, V Agrahari, D Pal, M Ashim K. Recent Patents on Nanomedicine 4 (1), 57-68, 2014 | 22 | 2014 |
| Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells V Khurana, AD Vadlapudi, RK Vadlapatla, D Pal, AK Mitra Current eye research 40 (5), 457-469, 2015 | 18 | 2015 |
| Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells V Khurana, D Kwatra, D Pal, AK Mitra International journal of pharmaceutics 474 (1-2), 14-24, 2014 | 18 | 2014 |
| Emerging nanotechnology for stem cell therapy V Khurana, D Kwatra, S Shah, A Mandal, AK Mitra Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices …, 2017 | 7 | 2017 |
| Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters D Kwatra, AD Vadlapudi, RK Vadlapatla, V Khurana, D Pal, AK Mitra Drug metabolism and drug interactions 29 (2), 101-110, 2014 | 7 | 2014 |
Mukul MinochaAmgen在 amgen.com 的电子邮件经过验证
Mukul MinochaAmgen在 amgen.com 的电子邮件经过验证